Literature DB >> 24863948

Prediction of thyroid extracapsular extension with cervical lymph node metastases (ECE-LN) by CEUS and BRAF expression in papillary thyroid carcinoma.

Xi Wei1, Ying Li, Sheng Zhang, Ming Gao.   

Abstract

The aim of our study was to find a specific imaging (contrast-enhanced ultrasound, CEUS) to detect extracapsular extension and cervical lymph node metastases (ECE-LNM) that associated with BRAF protein expression in papillary thyroid carcinoma (PTC). Preoperative utrasonography (US) or CEUS was performed in the diagnosis of extracapsular extension (ECE) in 317 patients with 369 PTC. BRAF protein status was tested on the primary tumor and lymph node involvement. The diagnostic accuracy of CEUS and US was evaluated after thyroid surgery. The association between CEUS and BRAF expression were then analyzed to investigate the diagnostic value of ECE-LNM in PTC. The sensitivity and specificity of CEUS were higher than those in US in the diagnosis of ECE in patients with PTC (91.1, 86.5 vs 49, 55 %). BRAF protein overexpression were significantly associated with ECE (P = 0.0003) and lymph node metastasis (LNM) positive cases (P = 0.0014). The results of CEUS, not US, have a significant correlation with BRAF expression status in PTC samples (P < 0.0001). Associated with BRAF protein expression status, the routine preoperative CEUS could have a good value in the diagnosis of ECE-LNM in PTC and facilitate a surgeon to improve further clinical management.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24863948     DOI: 10.1007/s13277-014-2119-2

Source DB:  PubMed          Journal:  Tumour Biol        ISSN: 1010-4283


  26 in total

Review 1.  Clinical review 128: Current approaches to primary therapy for papillary and follicular thyroid cancer.

Authors:  E L Mazzaferri; R T Kloos
Journal:  J Clin Endocrinol Metab       Date:  2001-04       Impact factor: 5.958

2.  Utility of BRAF protein overexpression in predicting the metastasis potential of papillary thyroid carcinoma.

Authors:  Lu Feng; Mei Li; Qiu-Ping Zhang; Zheng-Ai Piao; Zhao-Hui Wang; Shen Lv
Journal:  Oncol Lett       Date:  2010-11-23       Impact factor: 2.967

3.  Increasing incidence of thyroid cancer in the United States, 1973-2002.

Authors:  Louise Davies; H Gilbert Welch
Journal:  JAMA       Date:  2006-05-10       Impact factor: 56.272

4.  Preoperative diagnosis of thyroid adenomas using high resolution contrast-enhanced ultrasound (CEUS).

Authors:  A Agha; E M Jung; M Janke; M Hornung; M Georgieva; H J Schlitt; A G Schreyer; C Strosczcynski; S Schleder
Journal:  Clin Hemorheol Microcirc       Date:  2013-01-01       Impact factor: 2.375

5.  Localization of cervical node metastasis of papillary thyroid carcinoma.

Authors:  E Mirallié; J Visset; C Sagan; A Hamy; M F Le Bodic; J Paineau
Journal:  World J Surg       Date:  1999-09       Impact factor: 3.352

6.  Risk of malignancy in nonpalpable thyroid nodules: predictive value of ultrasound and color-Doppler features.

Authors:  Enrico Papini; Rinaldo Guglielmi; Antonio Bianchini; Anna Crescenzi; Silvia Taccogna; Francesco Nardi; Claudio Panunzi; Roberta Rinaldi; Vincenzo Toscano; Claudio M Pacella
Journal:  J Clin Endocrinol Metab       Date:  2002-05       Impact factor: 5.958

7.  The effects of surgery, radioiodine, and external radiation therapy on the clinical outcome of patients with differentiated thyroid carcinoma.

Authors:  R W Tsang; J D Brierley; W J Simpson; T Panzarella; M K Gospodarowicz; S B Sutcliffe
Journal:  Cancer       Date:  1998-01-15       Impact factor: 6.860

8.  Prognostic factors for persistent or recurrent disease of papillary thyroid carcinoma with neck lymph node metastases and/or tumor extension beyond the thyroid capsule at initial diagnosis.

Authors:  Sophie Leboulleux; Carole Rubino; Eric Baudin; Bernard Caillou; Dana M Hartl; Jean-Michel Bidart; Jean-Paul Travagli; Martin Schlumberger
Journal:  J Clin Endocrinol Metab       Date:  2005-07-19       Impact factor: 5.958

9.  Preoperative prediction of central lymph node metastasis in thyroid papillary microcarcinoma using clinicopathologic and sonographic features.

Authors:  Kyung-Eun Kim; Eun-Kyung Kim; Jung Hyun Yoon; Kyung Hwa Han; Hee Jung Moon; Jin Young Kwak
Journal:  World J Surg       Date:  2013-02       Impact factor: 3.352

10.  Nodal status of central lymph nodes as a negative prognostic factor for papillary thyroid carcinoma.

Authors:  Yoon Se Lee; Yun-Sung Lim; Jin-Choon Lee; Soo-Geun Wang; In-Ju Kim; Seok-Man Son; Dong Hoon Shin; Byung-Joo Lee
Journal:  J Surg Oncol       Date:  2013-05-02       Impact factor: 3.454

View more
  14 in total

1.  Contrast-enhanced ultrasound: a valuable modality for extracapsular extension assessment in papillary thyroid cancer.

Authors:  Yan Zhang; Xia Zhang; Jie Li; Qian Cai; Zhi Qiao; Yu Kun Luo
Journal:  Eur Radiol       Date:  2021-01-07       Impact factor: 5.315

2.  Prediction of cervical lymph node metastasis with contrast-enhanced ultrasound and association between presence of BRAFV600E and extrathyroidal extension in papillary thyroid carcinoma.

Authors:  Jia Zhan; Long-Hui Zhang; Qing Yu; Chao-Lun Li; Yue Chen; Wen-Ping Wang; Hong Ding
Journal:  Ther Adv Med Oncol       Date:  2020-08-06       Impact factor: 8.168

3.  The prediction of survival of patients with gastric cancer with PD-L1 expression using contrast-enhanced ultrasonography.

Authors:  Lin-Ang Wang; Xi Wei; Qing Li; Lin Chen
Journal:  Tumour Biol       Date:  2015-12-15

4.  BRAF Mutations in an Italian Regional Population: Implications for the Therapy of Thyroid Cancer.

Authors:  Eleonora Monti; Michela Bovero; Lorenzo Mortara; Giorgia Pera; Simonetta Zupo; Elena Gugiatti; Mariella Dono; Barbara Massa; Gian Luca Ansaldo; Giusti Massimo
Journal:  Int J Endocrinol       Date:  2015-11-26       Impact factor: 3.257

5.  Values of ultrasound features and MMP-9 of papillary thyroid carcinoma in predicting cervical lymph node metastases.

Authors:  Yan Zhang; Yu-Kun Luo; Ming-Bo Zhang; Jie Li; Chang-Tian Li; Jie Tang; Jun-Lai Li
Journal:  Sci Rep       Date:  2017-07-27       Impact factor: 4.379

6.  Utility of quantitative contrast-enhanced ultrasound for the prediction of extracapsular extension in papillary thyroid carcinoma.

Authors:  Yi Liu; Hua Liu; Chang-Lin Qian; Mei-Sui Lin; Feng-Hua Li
Journal:  Sci Rep       Date:  2017-05-03       Impact factor: 4.379

7.  Effect of chronic lymphocytic thyroiditis on the efficacy and safety of ultrasound-guided radiofrequency ablation for papillary thyroid microcarcinoma.

Authors:  Yan Zhang; Ming-Bo Zhang; Yu-Kun Luo; Jie Li; Ying Zhang; Jie Tang
Journal:  Cancer Med       Date:  2019-07-30       Impact factor: 4.452

8.  Prediction of survival prognosis of non-small cell lung cancer by APE1 through regulation of Epithelial-Mesenchymal Transition.

Authors:  Xi Wei; Qing Li; Ying Li; Wei Duan; Chongbiao Huang; Xiangqian Zheng; Lei Sun; Jingtao Luo; Dong Wang; Sheng Zhang; Xiaojie Xin; Ming Gao
Journal:  Oncotarget       Date:  2016-05-10

9.  AT101 exerts a synergetic efficacy in gastric cancer patients with 5-FU based treatment through promoting apoptosis and autophagy.

Authors:  Xi Wei; Wei Duan; Ying Li; Sheng Zhang; Xiaojie Xin; Lei Sun; Ming Gao; Qing Li; Dong Wang
Journal:  Oncotarget       Date:  2016-06-07

10.  Clinical outcomes of radiofrequency ablation for multifocal papillary thyroid microcarcinoma versus unifocal papillary thyroid microcarcinoma: a propensity-matched cohort study.

Authors:  Lin Yan; Mingbo Zhang; Qing Song; Fang Xie; Yukun Luo
Journal:  Eur Radiol       Date:  2021-08-06       Impact factor: 5.315

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.